Abstract:Acrylamide (ACR) exposure and consequent health hazards are alarming public health issues that attract worldwide concern. The World Health Organization urges more researches into health hazards from ACR exposure. However, whether and how ACR exposure increases cardiovascular risk remain unclear, and we sought to address these issues in this prospective cohort study conducted on 3024 general adults with 3-year follow-up (N=871 at follow-up). Individual urinary ACR metabolites (N-Acetyl-S-(2-carbamoylethyl)-L-cysteine [AAMA] and N-Acetyl-S-(2-carbamoyl-2-hydroxyethyl)-L-cysteine [GAMA]) as credible biomarkers of ACR exposure were detected to assess their cross-sectional and longitudinal relationships with 10-year cardiovascular disease (CVD) risk, a well measure of overall cardiovascular risk. Besides, biomarkers of oxidative stress (urinary 8-hydroxy-deoxyguanosine [8-OHdG] and 8-iso-prostaglandin-F2α [8-iso-PGF2α]) and inflammation (circulating mean platelet volume [MPV] and plasma C-reactive protein [CRP]) as well as plasma transforming growth factor-β1 (TGF-β1) were measured to assess their mediating/mechanistic roles in the relationships of ACR metabolites with 10-year CVD risk. We found AAMA, GAMA, and ΣUAAM (AAMA+GAMA) were cross-sectionally and longitudinally related to increased 10-year CVD risk with odds ratios (95% confidence intervals [CIs]) of 1.32 (1.04, 1.70), 1.81 (1.36, 2.40), and 1.40 (1.07, 1.82), respectively, and risk ratios (95% CIs) of 1.99 (1.10, 3.60), 2.48 (1.27, 4.86), and 2.13 (1.15, 3.94), respectively. Furthermore, 8-OHdG, 8-iso-PGF2α, MPV, CRP, and TGF-β1 were found to significantly mediate 8.06-48.92% of the ACR metabolites-associated 10-year CVD risk increment. In summary, daily ACR exposure of general adults was cross-sectionally and longitudinally associated with increased cardiovascular risk, which was partly mediated by oxidative stress, inflammation, and TGF-β1, suggesting for the first time that ACR exposure may well increase cardiovascular risk of general adult population partly by mechanisms of inducing oxidative stress, inflammation, and TGF-β1. Our findings have important public health implications that provide potent epidemiological evidence and vital mechanistic insight into cardiovascular risk increment from ACR exposure.

Unraveling the Serum Metabolomic Profile of Acrylamide-Induced Cardiovascular Toxicity

Nontargeted metabolomics-based mapping urinary metabolic fingerprints after exposure to acrylamide

Toxicokinetics and Internal Exposure of Acrylamide: New Insight into Comprehensively Profiling Mercapturic Acid Metabolites As Short-Term Biomarkers in Rats and Chinese Adolescents.

Comprehensive Profiling of Mercapturic Acid Metabolites from Dietary Acrylamide As Short-Term Exposure Biomarkers for Evaluation of Toxicokinetics in Rats and Daily Internal Exposure in Humans Using Isotope Dilution Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry.

Metabolomics Analysis Using Matrix-Assisted Diffusion-Ordered Spectroscopy (DOSY) and Its Application in Acrylamide-Induced Cardiovascular Toxicity

Research progress in biomarker analysis and risk assessment of acrylamide exposure in vivo

Effect of oral exposure to acrylamide on biochemical and hematologic parameters in Wistar rats

Characterization of Acrylamide-Induced Oxidative Stress and Cardiovascular Toxicity in Zebrafish Embryos.

Metabolomics strategy comprehensively unveils the effect of catechins intervention on the biomarkers of exposure to acrylamide and biomarkers of cardiometabolic risk

Rapid Simultaneous Determination of Cascade Metabolites of Acrylamide in Urine for Toxicokinetics Profiles and Short-Term Dietary Internal Exposure.

Acrylamide Exposure and Cardiovascular Risk: A Systematic Review

Comprehensive Profile of DNA Adducts As Both Tissue and Urinary Biomarkers of Exposure to Acrylamide and Chemo-Preventive Effect of Catechins in Rats.

Phosphatidylcholine Protects Against the Hepatotoxicity of Acrylamide Via Maintaining Metabolic Homeostasis of Glutathione and Glycerophospholipid

Effects of Acrylamide on the Levels of Neurofilament Subunit Proteins in Rat Cerebellum

Acrylamide Induces Spatiotemporal Metabolic Profiling Disturbance Via Targeting Taurine and Hypotaurine Metabolism During Early Zebrafish Development

Metabolism of Acrylamide: Interindividual and Interspecies Differences As Well As the Application As Biomarkers

Acrylamide Inhibits Autophagy, Induces Apoptosis and Alters Cellular Metabolic Profiles.

Biomarker Analysis of Hemoglobin Adducts of Acrylamide and Glycidamide Enantiomers for Mid-Term Internal Exposure Assessment by Isotope Dilution Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry.

Reconstructing hepatic metabolic profile and glutathione-mediated metabolic fate of acrylamide

A systematic review: on the mercaptoacid metabolites of acrylamide, N-acetyl-S-(2-carbamoylethyl)-L-cysteine

Acrylamide exposure increases cardiovascular risk of general adult population probably by inducing oxidative stress, inflammation, and TGF-β1: A prospective cohort study